Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
Pharmaceuticals (Basel) ; 16(8)2023 Aug 07.
Artigo em Inglês | MEDLINE | ID: mdl-37631028

RESUMO

Leishmaniasis is a group of infectious diseases caused by protozoan parasites that belong to the genus Leishmania. Currently, there is no human vaccine, and the available treatments are associated with toxicity, high cost, and the emergence of resistant strains. These factors highlight the need to identify new antileishmanial candidates. In this study, we synthesized twenty-four methoxylated cinnamides containing 1,2,3-triazole fragments and evaluated their antileishmanial activity against the Leishmania braziliensis species, which is the main etiological agent responsible for American Tegumentary Leishmaniasis (ATL). The cinnamides were synthetically prepared using nucleophilic acyl substitution and copper(I)-catalyzed azide-alkyne cycloaddition (CuAAC) reactions. The compounds were characterized using infrared, nuclear magnetic resonance, and high-resolution mass spectrometry techniques. We performed preliminary studies to evaluate the biological activity of these compounds against L. braziliensis promastigotes and axenic amastigotes. Compound 28, N-((1-(7-(diethylamino)-2-oxo-2H-chromen-3-yl)-1H-1,2,3-triazole-4-yl) methyl)-3,4-dimethoxy cinnamide, demonstrated relevant antileishmanial activity with low toxicity in murine cells. The selectivity index values for this compound were superior compared with data obtained using amphotericin B. Furthermore, this cinnamide derivative reduced the infection percentage and number of recovered amastigotes in L. braziliensis-infected macrophages. It also induced an increase in reactive oxygen species production, depolarization of the mitochondrial potential, and disruption of the parasite membrane. Taken together, these findings suggest that this synthetic compound holds potential as an antileishmanial candidate and should be considered for future studies in the treatment of ATL.

2.
Pathogens ; 12(2)2023 Feb 14.
Artigo em Inglês | MEDLINE | ID: mdl-36839584

RESUMO

Chagas disease remains a neglected disease that is considered to be a public health problem. The early diagnosis of cases is important to improve the prognosis of infected patients and prevent transmission. Serological tests are the method of choice for diagnosis. However, two serological tests are currently recommended to confirm positive cases. In this sense, more sensitive and specific serological tests need to be developed to overcome these current diagnosis problems. This study aimed to develop a new recombinant multiepitope protein for the diagnosis of Chagas disease, hereafter named rTC. The rTC was constructed based on amino acid sequences from different combinations of Trypanosoma cruzi antigens in the same polypeptide and tested using an enzyme-linked immunosorbent assay (ELISA) to detect different types of Chagas disease. rTC was able to discriminate between indeterminate (IND) and cardiac (CARD) cases and cross-reactive diseases, as well as healthy samples, with 98.28% sensitivity and 96.67% specificity, respectively. These data suggest that rTC has the potential to be tested in future studies against a larger serological panel for the diagnosis of Chagas disease.

3.
Artigo em Inglês | MEDLINE | ID: mdl-29785196

RESUMO

BACKGROUND: The development of new therapeutic strategies to treat patients for leishmaniasis has become a priority. The antileishmanial activity of the strychnobiflavone flavonoid was recently demonstrated against Leishmania amazonensis and Leishmania infantum amastigotes and promastigotes. The biological effect of this molecule was identified due to its capacity to interfere in the parasite mitochondrial membrane; however, the underlying molecular mechanism remains unclear. METHODS AND RESULTS: In this study, a computational approach using bioinformatics was performed to screen biological targets of strychnobiflavone in L. infantum. Computational programs, such as the target fishing approach and molecular docking assays, were used. Results showed that the putative pathway targeted by strychnobiflavone in L. infantum is the methylglyoxal degradation superpathway, and one hydrolase-like protein was predicted to be the molecular target of this flavonoid in the parasites. CONCLUSION: In this context, this study provides the basis for understanding the mechanism of action of strychnobiflavone in L. infantum and presents a strategy based on bioinformatics programs to screen targets of other molecules with biological action against distinct pathogens.

4.
Basic Clin Pharmacol Toxicol ; 123(3): 236-246, 2018 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-29481714

RESUMO

In this study, a quinoline derivate, clioquinol (5-chloro-7-iodoquinolin-8-ol), was evaluated against Leishmania amazonensis and Leishmania infantum promastigotes and amastigotes. The cytotoxicity in murine macrophages and human red blood cells, as well as the efficacy in treating infected macrophages and the inhibition of infection using pre-treated parasites were also evaluated. Results showed that clioquinol inhibited L. amazonensis and L. infantum promastigotes with effective concentration 50% (EC50 ) values of 2.55 ± 0.25 and 1.44 ± 0.35 µg/mL, respectively, and of 1.88 ± 0.13 and 0.98 ± 0.17 µg/mL against axenic amastigotes, respectively. The cytotoxic EC50 concentrations of clioquinol in murine macrophages and human red blood cells were, respectively, 255 ± 23 and 489 ± 20 µg/mL. With these results, the selectivity index was calculated, showing values of 99.9 and 177.1 against promastigotes, respectively, and of 135.6 and 260.1 against axenic amastigotes, respectively. Significant reductions in the percentage of infected macrophages after treatment using clioquinol were also observed, as well as when parasites were pre-treated with clioquinol and used to infect murine macrophages. The mechanism of action of clioquinol was investigated in L. amazonensis, and results revealed morphological and biochemical alterations in the clioquinol-treated parasites, including reduction in cell volume, loss of mitochondrial membrane potential, increase in the ROS production and rupture of the plasma membrane. The externalization of phosphatidylserine (PS) at the cell surface was evaluated in treated parasites that had been doubly labelled with annexin and propidium iodide (PI). The results showed no significant difference for PS exposure when compared to the untreated control, although a significant increase in the PI/annexin V-labelled cell population was found in the treated parasites. Results suggest that clioquinol induces a discontinuity of the parasite membrane, possibly related to a characteristic event of cell death caused by necrosis. This study demonstrates, for the first time, the antileishmanial activity of clioquinol against two relevant Leishmania species and suggests that the mitochondria of the parasites may be a possible biological target leading to parasite necrosis. Our findings suggest that clioquinol may have a potential application in treatment of leishmaniasis and further studies should be performed in infected mammalian hosts.


Assuntos
Antiprotozoários/farmacologia , Clioquinol/farmacologia , Leishmania infantum/efeitos dos fármacos , Leishmania mexicana/efeitos dos fármacos , Animais , Antiprotozoários/administração & dosagem , Clioquinol/administração & dosagem , Eritrócitos/efeitos dos fármacos , Feminino , Humanos , Leishmaniose/tratamento farmacológico , Leishmaniose/parasitologia , Macrófagos/metabolismo , Macrófagos/parasitologia , Potencial da Membrana Mitocondrial/efeitos dos fármacos , Camundongos , Camundongos Endogâmicos BALB C , Mitocôndrias/efeitos dos fármacos , Mitocôndrias/parasitologia , Espécies Reativas de Oxigênio/metabolismo
5.
Parasitol Res ; 117(2): 391-403, 2018 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-29248978

RESUMO

Leishmaniasis has become a significant public health issue in several countries in the world. New products have been identified to treat against the disease; however, toxicity and/or high cost is a limitation. The present work evaluated the antileishmanial activity of a new naphthoquinone derivate, Flau-A [2-(2,3,4-tri-O-acetyl-6-deoxy-ß-L-galactopyranosyloxy)-1,4-naphthoquinone], against promastigote and amastigote-like stages of Leishmania amazonensis and L. infantum. In addition, the cytotoxicity in murine macrophages and human red cells was also investigated. The mechanism of action of Flau-A was assessed in L. amazonensis as well as its efficacy in treating infected macrophages and inhibiting infection of pretreated parasites. Results showed that Flau-A was effective against promastigotes and amastigote-like forms of both parasite species, as well as showed low toxicity in mammalian cells. Results also highlighted the morphological and biochemical alterations induced by Flau-A in L. amazonensis, including loss of mitochondrial membrane potential, as well as increased reactive oxygen species production, cell shrinkage, and alteration of the plasma membrane integrity. The present study demonstrates for the first time the antileishmanial activity of Flau-A against two Leishmania species and suggests that the mitochondria of the parasites may be the main target organelle. Data shown here encourages the use of this molecule in new studies concerning treatment against Leishmania infection in mammalian hosts.


Assuntos
Antiprotozoários/farmacologia , Leishmania infantum/efeitos dos fármacos , Leishmania mexicana/efeitos dos fármacos , Naftoquinonas/farmacologia , Animais , Eritrócitos/efeitos dos fármacos , Feminino , Humanos , Macrófagos/efeitos dos fármacos , Macrófagos/parasitologia , Potencial da Membrana Mitocondrial/efeitos dos fármacos , Camundongos , Camundongos Endogâmicos BALB C , Mitocôndrias/efeitos dos fármacos , Naftoquinonas/química
6.
Acta Trop ; 158: 220-230, 2016 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-26976272

RESUMO

Vaccination can be considered the most cost-effective strategy to control neglected diseases, but nowadays there is not an effective vaccine available against leishmaniasis. In the present study, a vaccine based on the combination of the Leishmania-specific hypothetical protein (LiHyD) with saponin was tested in BALB/c mice against infection caused by Leishmania major and Leishmania braziliensis species. This antigen was firstly identified in Leishmania infantum and showed to be protective against infection of BALB/c mice using this parasite species. The immunogenicity of rLiHyD/saponin vaccine was evaluated, and the results showed that immunized mice produced high levels of IFN-γ, IL-12 and GM-CSF after in vitro stimulation with rLiHyD, as well as by using L. major or L. braziliensis protein extracts. After challenge, vaccinated animals showed significant reductions in the infected footpad swellings, as well as in the parasite burden in the infection site, liver, spleen, and infected paws draining lymph nodes, when compared to those that were inoculated with the vaccine diluent (saline) or immunized with saponin. The immunization of rLiHyD without adjuvant was not protective against both challenges. The partial protection obtained by the rLiHyD/saponin vaccine was associated with a parasite-specific IL-12-dependent IFN-γ secretion, which was produced mainly by CD4(+) T cells. In these animals, a decrease in the parasite-mediated IL-4 and IL-10 responses, associated with the presence of high levels of LiHyD- and parasite-specific IgG2a isotype antibodies, were also observed. The present study showed that a hypothetical protein that was firstly identified in L. infantum, when combined to a Th1 adjuvant, was able to confer a cross-protection against highly infective stationary-phase promastigotes of two Leishmania species causing tegumentary leishmaniasis.


Assuntos
Leishmania braziliensis/imunologia , Leishmania infantum/imunologia , Leishmania major/imunologia , Vacinas contra Leishmaniose/imunologia , Animais , Anticorpos Antiprotozoários/sangue , Citocinas/biossíntese , Feminino , Leishmaniose/prevenção & controle , Camundongos , Camundongos Endogâmicos BALB C , Linfócitos T/imunologia , Vacinação
7.
Odonto (Säo Bernardo do Campo) ; 20(40): 7-12, jul.-dez. 2012. tab
Artigo em Português | LILACS, BBO - Odontologia | ID: lil-790174

RESUMO

Objetivo: analisar os valores pagos por danos estéticos, morais e materiais nos processos de responsabilidade civil contra o Cirurgião-dentista julgados no Tribunal de Justiça do Estado do Rio Grande do Sul nos anos de 2007 a 2010, identificar no teor dos julgamentos se foi utilizado pelo perito ou juiz o método descritivo na avaliação da alteração estética, bem como destacar a importância de equipará-lo a uma das categorias ou adjetivos referida em uma escala gradual qualificativa de gravidade crescente. Metodologia: Foram analisados julgamentos de processos civis envolvendo Cirurgiões- dentistas, baixadas (download) e impressas, por meio de busca eletrônica no site do Tribunal de Justiça do Estado do Rio Grande do Sul do ano de 2007 até o ano de 2010. Utilizou-se na amostra apenas os textos produzidos pelos magistrados, fazendo a análise do inteiro teor somente nos casos em que foram deferidos danos estéticos. Nesses, verificou-se se fora utilizada algum parâmetro qualificativo ou numérico. Conclusão: Os processos relacionados à responsabilidade profissional do Cirurgiãodentista mostraram uma tendência dos magistrados deferirem mais indenizações por danos morais do que danos materiais, bem como de valorar num patamar quantitativo alto os pedidos por danos estéticos, sendo esses, na média, maior que os danos materiais e morais. De acordo com os julgamentos analisados, não se identificou na valoração dos danos estéticos uma análise objetiva e comparativa. Os parâmetros indicados no método descritivo sempre deverão ser utilizados para mostrar sua característica e importância nas avaliações das alterações estéticas, necessitando para tal atribuir pontos ou porcentagens com escalas numéricas.


Objective: analyzing the amount paid by aesthetic, moral and material damages in civil liability processes against the Dentist judged at the Court of the State of Rio Grande do Sul from 2007 to 2010, identifying in the content of the trials if the expert or judge used the descriptive method in the evaluation of aesthetic changes as well as highlighting the importance of matching it to one of the categories referred to in qualifying graduated scale of increasing severity. Methodology: We have analyzed trials of civil cases involving Dentists, both downloaded and printed, through electronic search on the site of the Court of the State of Rio Grande do Sul in 2007 by the year 2010. Only the texts produced by the magistrates were used in the sample, making the analysis of the full content only in cases that have been granted cosmetic damage. In these, we have checked whether any qualifier or numeric parameter had been used or not. Conclusion: The processes related to the professional responsibility of the Dentists have showed a tendency of judges to defer more compensation for moral damages to material damages, as well as give value in a high-level requests referring to disfigurement -on average larger than the material and moral damages. According to the trialsanalyzed no objective and comparative analysis were identified in the assessment of cosmetic damage. The parameters indicated in the descriptive method should always be used to show the characteristics and importance of the evaluations of cosmetic changes, for which they need to assign percentage points or numerical scales.


Assuntos
Humanos , Compensação e Reparação/legislação & jurisprudência , Decisões Judiciais , Odontólogos/legislação & jurisprudência , Brasil , Responsabilidade Civil , Estética , Odontologia Legal , Prova Pericial/legislação & jurisprudência
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...